前列腺癌放疗中水凝胶间隔物直肠周围分布:对称性对直肠剂量降低的影响及直肠壁浸润的临床后果
该研究基于一项前瞻性随机对照试验中149例接受经会阴水凝胶间隔物注射的前列腺癌患者,用T2加权MRI评估间隔物中线对称性和直肠壁浸润(RWI)。结果显示47.7%患者对称放置,50.9%有某种程度不对称,仅1.3%为远外侧分布;不对称性增加时直肠剂量降低程度减弱,但除最不对称的1.3%外均有显著直肠剂量降低(P < .05)。RWI见于6.0%患者,与操作相关不良事件或急晚期直肠毒性无相关性。
要点
- 水凝胶间隔物对称放置者占47.7%,不对称者占50.9%,远外侧分布仅1.3%。
- 不对称性增加时直肠剂量降低程度减弱,但除最不对称1.3%外仍有显著剂量降低。
- 直肠壁浸润见于6.0%患者,与不良事件及急晚期直肠毒性无相关性。
核心结论
- 即使水凝胶间隔物放置不对称,仍可实现显著的直肠剂量降低。
- 直肠壁水凝胶浸润与患者并发症无相关性。
研究设计与样本
- 研究评估一项前瞻性随机对照试验中149例接受经会阴水凝胶间隔物注射的前列腺癌患者的T2加权MRI。
- 采用半定性评分系统评估水凝胶间隔物中线对称性和直肠壁浸润。
- 对称性与直肠剂量降低的相关性采用Student t检验(单尾,配对),直肠壁浸润与急晚期直肠毒性的相关性采用Fisher精确检验。
- 所有患者均在间隔物注射前创建对照治疗计划。
主要发现
- 71例(47.7%)患者在前列腺中叶及中叶上、下1 cm处水凝胶间隔物对称放置于中线。
- 其余78例(50.9%)患者有某种程度不对称,仅2例(1.3%)水凝胶间隔物呈远外侧分布(即>2 cm)。
- 随着水凝胶间隔物变得更不对称,相对于对照计划的直肠剂量降低程度减弱。
- 除最不对称的1.3%外,所有患者均有显著直肠剂量降低(P < .05)。
- 直肠壁水凝胶间隔物浸润见于9例(6.0%)患者。
临床怎么用
- 水凝胶间隔物放置不对称时仍可能获得显著直肠剂量降低,不应仅因不对称而放弃剂量降低预期。
- 直肠壁水凝胶浸润与并发症无相关性,可据此进行临床解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Hydrogel prostate-rectum spacers, biomaterials placed between the prostate and rectum, continue to gain interest as a method to reduce or limit rectal dose during dose escalated prostate cancer radiation therapy. Because the spacer is initially injected into the perirectal space as a liquid, the final distribution can vary. The purpose of this study was to evaluate hydrogel spacer (SpaceOAR system) implantation and distribution from a recent prospective randomized control trial and correlate spacer symmetry with rectal dose reduction as well as rectal wall infiltration (RWI) to acute and late toxicity. METHODS AND MATERIALS: T2-weighted magnetic resonance imaging sets of 149 patients enrolled in a prospective clinical trial who received transperineal spacer injection were assessed for hydrogel spacer midline symmetry and RWI using a semiqualitative scoring system. Symmetry was then correlated to rectal dose reduction using a Student t test (1-tailed, paired), whereas a Fisher exact test was used to correlate RWI with acute and late rectal toxicity. All patients had control treatment plans created before spacer injection. RESULTS: Hydrogel spacer was symmetrically placed at midline for 71 (47.7%) patients at the prostate midgland as well as 1 cm superior and inferior to midgland. The remaining 78 (50.9%) patients had some level of asymmetry, with only 2 (1.3%) having far lateral distribution (ie, >2 cm) of hydrogel spacer. As the hydrogel spacer became more asymmetric, the level of rectal dose reduction relative to their control plans decreased. However, all but the most asymmetrical 1.3% had significant rectal dose reduction (P < .05). Rectal wall hydrogel spacer infiltration was seen in 9 (6.0%) patients. There was no correlation between RWI and procedure-related adverse events or acute/late rectal toxicity. CONCLUSIONS: Significant reduction of rectal dose can still be achieved even in the setting of asymmetric hydrogel spacer placement. RWI does not correlate with patient complications.
引用
- Fischer-Valuck BW, Chundury A, Gay H, et al. Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall. Pract Radiat Oncol. 2016. PMID: 28089528. doi:10.1016/j.prro.2016.10.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。